Two Sigma Advisers’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-135,300
| Closed | -$5.32M | – | 2657 |
|
|
2023
Q2 | $5.32M | Buy |
+135,300
| New | +$4.78M | 0.01% | 747 |
|
|
2023
Q1 | – | Sell |
-79,000
| Closed | -$1.69M | – | 2806 |
|
|
2022
Q4 | $1.69M | Sell |
79,000
-522,000
| -87% | -$11.1M | ﹤0.01% | 1321 |
|
|
2022
Q3 | $10.8M | Sell |
601,000
-1,027,900
| -63% | -$13.5M | 0.03% | 481 |
|
|
2022
Q2 | $15.7M | Buy |
1,628,900
+353,700
| +28% | +$4.44M | 0.04% | 382 |
|
|
2022
Q1 | $21.5M | Sell |
1,275,200
-21,000
| -2% | -$310K | 0.06% | 310 |
|
|
2021
Q4 | $21.7M | Buy |
1,296,200
+439,500
| +51% | +$7.2M | 0.05% | 290 |
|
|
2021
Q3 | $13.9M | Buy |
856,700
+497,100
| +138% | +$5.41M | 0.04% | 421 |
|
|
2021
Q2 | $2.27M | Buy |
359,600
+115,600
| +47% | +$746K | 0.01% | 1234 |
|
|
2021
Q1 | $1.51M | Buy |
244,000
+54,700
| +29% | +$332K | ﹤0.01% | 1414 |
|
|
2020
Q4 | $1.31M | Buy |
189,300
+69,500
| +58% | +$445K | ﹤0.01% | 1450 |
|
|
2020
Q3 | $676K | Sell |
119,800
-13,200
| -10% | -$62.9K | ﹤0.01% | 1683 |
|
|
2020
Q2 | $678K | Buy |
133,000
+58,000
| +77% | +$242K | ﹤0.01% | 1757 |
|
|
2020
Q1 | $258K | Buy |
75,000
+47,600
| +174% | +$278K | ﹤0.01% | 2077 |
|
|
2019
Q4 | $235K | Sell |
27,400
-18,700
| -41% | -$66.8K | ﹤0.01% | 2136 |
|
|
2019
Q3 | $52K | Sell |
46,100
-10,600
| -19% | -$12.3K | ﹤0.01% | 2152 |
|
|
2019
Q2 | $74K | Buy |
56,700
+900
| +2% | +$1.24K | ﹤0.01% | 2234 |
|
|
2019
Q1 | $79K | Sell |
55,800
-900
| -2% | -$1.26K | ﹤0.01% | 2210 |
|
|
2018
Q4 | $68K | Sell |
56,700
-90
| -0.2% | -$174 | ﹤0.01% | 2257 |
|
|
2018
Q3 | $134K | Sell |
56,790
-14,400
| -20% | -$35.9K | ﹤0.01% | 2137 |
|
|
2018
Q2 | $194K | Buy |
71,190
+24,000
| +51% | +$66.2K | ﹤0.01% | 2203 |
|
|
2018
Q1 | $129K | Sell |
47,190
-4,776
| -9% | -$13.8K | ﹤0.01% | 2200 |
|
|
2017
Q4 | $162K | Buy |
51,966
+5,976
| +13% | +$16.8K | ﹤0.01% | 2108 |
|
|
2017
Q3 | $130K | Sell |
45,990
-150,644
| -77% | -$407K | ﹤0.01% | 2103 |
|
|
2017
Q2 | $503K | Sell |
196,634
-263,856
| -57% | -$719K | ﹤0.01% | 1798 |
|
|
2017
Q1 | $1.69M | Sell |
460,490
-52,086
| -10% | -$220K | 0.01% | 1342 |
|
|
2016
Q4 | $2.48M | Buy |
+512,576
| New | +$15.2M | 0.01% | 1070 |
|
|
2016
Q2 | – | Sell |
-9,400
| Closed | -$397K | – | 2232 |
|
|
2016
Q1 | $397K | Buy |
+9,400
| New | +$479K | ﹤0.01% | 1562 |
|
|
2015
Q2 | – | Sell |
-5,200
| Closed | -$242K | – | 2122 |
|
|
2015
Q1 | $242K | Buy |
+5,200
| New | +$270K | ﹤0.01% | 1668 |
|
Two Sigma Advisers's ISEE Position: Q3 2023 in Review
Two Sigma Advisers sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 135,300 shares — an estimated $5.32M sold.
Two Sigma Advisers first reported a position in ISEE in Q1 2015 and held it in 28 quarters. The position peaked at $21.7M in Q4 2021. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Two Sigma Advisers reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Two Sigma Advisers sold 135,300 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $5.32M.
- Two Sigma Advisers first reported a position in IVERIC bio, Inc. Common Stock in Q1 2015 and held it in 28 quarters.
- Two Sigma Advisers's IVERIC bio, Inc. Common Stock position peaked at $21.7M in Q4 2021.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Two Sigma Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.